DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The “Global Single Cell Analysis Market - Segmented by Cell type, Technique, Application, End-User and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.The single cell analysis market is expected to grow at a CAGR of about 17% during the forecast period.Growth of the market is primarily driven by the technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and pharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.
Growing Investments in Cancer ResearchThe rise in acquired resistance against systemic therapies is constantly happening due to the generation of variant cancer cells which leads to, the inability to cure advanced cancer patients. Circulating tumor cells are gaining increasing clinical attention because they may enable the monitoring cancer progression and adjustment of treatment.Implementation of technologies like single cell analysis in standardized and automated workflows in clinical diagnostics could provide valuable information for real-time monitoring of cancer and eventually new therapeutic strategies for the benefit of patients. This will lead to the growth of this market.Other factors that will lead this market to grow include technological advancements in single-cell analysis products, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine and increasing incidence and prevalence of chronic and infectious diseases.Other Key HighlightsHigh Cost of Single-Cell Analysis ProductsAsia-Pacific to Emerge as the Fastest Growing Region
Notable Development in the MarketSingle-Cell RNA Sequencing Reveals Neuronal Diversity. Using a new approach to analyze the transcriptomes of thousands of individual cell nuclei in postmortem brains, researchers identify multiple neuronal subtypes.Companies FeaturedAgilent TechnologiesBeckman Coulter Inc. (A Subsidiary of Danaher Corporation)Becton, Dickinson & CompanyBio-Rad Laboratories Inc.Fluidigm CorporationGE HealthcareIllumina Inc.Merck KGaAQiagen N.V.Thermo Fisher Scientific Inc.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/vpd8zt/global_single?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005354/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/06/2018 05:13 AM/DISC: 09/06/2018 05:13 AM